New results from the D3 (PENTA-21) trial, sponsored by Fondazione Penta ETS, add to the evidence that dolutegravir-based treatment remains a strong option for children living with HIV, even when the H...

Children with community-acquired pneumonia are usually treated with an injectable antibiotic for five days. This often means staying in hospital for the full treatment period, even when they are well

Fondazione Penta ETS and the Medicines Patent Pool (MPP) have signed a Memorandum of Understanding (MoU), formalising a strategic collaboration to support the development and equitable access of prior...

A protocol paper describing part of the PregInPoxVac study has been published in Vaccine. The paper outlines the design of a phase 3 trial evaluating the safety and immunogenicity of two-dose Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine regimens in children aged 4 to under 24 months living in the Democratic Republic of the Congo (DRC).

"In 2025, PentaTr@ining marked an important milestone: twenty years of turning paediatric infectious disease research into tangible improvements in maternal and child healthcare. What began as a Europ...

NeoIPC invites you to join the next session in the NeoNET Africa online Seminar Series 2026, taking place on 23 July 2026, 15:00–16:00 CEST/SAST. NeoNET Africa is a network dedicated to tackling the p...

YouTube video by Penta Child Health Research

From January 19–20, 2026, the PediSEP-1 consortium gathered in Mombasa, Kenya, for the official launch the project, designed to move paediatric care away from a “one-size-fits-all” approach and toward...